πŸ‡ΊπŸ‡Έ FDA
Patent

US 11827690

ApoC-II mimetic peptides

granted A61KA61K38/00A61K38/1709

Quick answer

US patent 11827690 (ApoC-II mimetic peptides) held by United State of America, As Represented by the Secretary, Dept. of Health and Human Services expires Mon Nov 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
United State of America, As Represented by the Secretary, Dept. of Health and Human Services
Grant date
Tue Nov 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K38/00, A61K38/1709, A61K38/1722, A61K9/0019